Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical Infectious Diseases

• Publication date

  2015-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/cid/ciu849PMID 25365974PMCID PMC4366579
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies.

  2015cited by this paper
• Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.

  2014cited by this paper
• Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings

  2014cited by this paper
• A trial of mass isoniazid preventive therapy for tuberculosis control.

  2014cited by this paper
• Prevalent Tuberculosis at HIV Diagnosis in Rio de Janeiro, Brazil: The TB/HIV in Rio (THRio) Cohort

  2014cited by this paper
• A Trial of Mass Isoniazid Preventive Therapy for Tuberculosis Control

  2014cited by this paper
• Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial.

  2013cited by this paper
• 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial.

  2011cited by this paper
• New regimens to prevent tuberculosis in adults with HIV infection.

  2011cited by this paper
• Recomendações para terapia antirretroviral em adultos infectados pelo HIV - 2008: suplemento III - tratamento e prevenção

  2010cited by this paper
• Treatment of latent tuberculosis infection in HIV infected persons.

  2010cited by this paper
• III Brazilian Thoracic Association Guidelines on tuberculosis.

  2009cited by this paper
• Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention

  2007cited by this paper
• Treatment of latent tuberculosis infection in HIV infected persons.

  2004cited by this paper
• Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults

  2001influential reference
• RECOMENDAÇÕES PARA TERAPIA ANTI-RETROVIRAL EM ADULTOS E ADOLESCENTES INFECTADOS PELO HIV - 2001

  2001cited by this paper
• Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil

  2001cited by this paper
• Recomendacoes para terapia anti-retroviral em adultos e adolescentes infectados pelo HIV - 2000

  2000cited by this paper
• HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners

  2000cited by this paper
• Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.

  1998cited by this paper
• Twice weekly tuberculosis preventive therapy in HIV infection in Zambia

  1998cited by this paper
• Isoniazid preventive therapy for tuberculosis in HIV‐1‐infected adults: results of a randomized controlled trial

  1997influential reference
• A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.

  1997cited by this paper
• A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.

  1997cited by this paper
• Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection.

  1993cited by this paper

• Comprehensive tuberculosis screening and preventive treatment in schools and congregate settings of India (2017–2024): a prospective study

  2026cites this paper
• Factors influencing the onset of tuberculosis in HIV-positive adults receiving highly active antiretroviral therapy in the coastal area of Kenya

  2025cites this paper
• Analysis of Tuberculosis Preventive Treatment Cascade Among People With Human Immunodeficiency Virus in Georgia: A Mixed-Methods Study

  2025cites this paper
• Long-term protection from TB preventive treatment among people with HIV in a high-burden tuberculosis setting: an observational cohort study from India.

  2025cites this paper
• Long-term protective effect of tuberculosis preventive therapy in a medium/high TB incidence setting.

  2024cites this paper
• Efficacy and Possible Mechanism(s) of Action of Gallium Tetraphenylporphyrin Nanoparticles against HIV-TB Coinfection in an In Vitro Granuloma Structure Model.

  2024cites this paper
• Preventive treatment for latent tuberculosis from Indian perspective

  2024cites this paper
• Incidence of tuberculosis (TB) disease in individuals diagnosed with TB infection following screening: a population-based cohort study in South Korea.

  2024cites this paper
• Factors associated with uptake of isoniazid preventive therapy among children living with HIV in Mwanza region, Tanzania: a cross-sectional study

  2024cites this paper
• TB prevalence among pregnant women with HIV in Rio de Janeiro, Brazil.

  2024cites this paper
• Sex differences in tuberculosis infection and disease among people with HIV

  2024cites this paper
• Impact and cost-effectiveness of short-course tuberculosis preventive treatment for household contacts and people with HIV in 29 high-incidence countries: a modelling analysis

  2023cites this paper
• Understanding patient-level costs of weekly isoniazid-rifapentine (3HP) among people living with HIV in Uganda.

  2023cites this paper
• Deaths among tuberculosis patients of the western state of India: A secondary record based analytical study on its determinants.

  2023cites this paper
• Burden of HIV and treatment outcomes among TB patients in rural Kenya: a 9-year longitudinal study

  2023cites this paper
• Multidrug-resistant bacteria with ESBL genes: a growing threat among people living with HIV/AIDS in Nepal

  2022cites this paper
• Effectiveness of a 6-Month Isoniazid on Prevention of Incident Tuberculosis Among People Living with HIV in Eritrea: A Retrospective Cohort Study

  2022cites this paper
• Landscape of TB Infection and Prevention among People Living with HIV

  2022cites this paper
• Latent Tuberculosis Infection and Isoniazid Preventive Therapy among Human Immunodeficiency Virus positive adults in Southern Nigeria

  2022cites this paper
• [Tuberculosis in adulthood - The Sk2-Guideline of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the diagnosis and treatment of adult tuberculosis patients].

  2022cites this paper
• Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden Settings

  2022cites this paper
• Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated isoniazid preventive therapy: A multi-center retrospective cohort study

  2022cites this paper
• HIV-associated tuberculosis

  2021cites this paper
• An evaluation of 6-month versus continuous isoniazid preventive therapy for M. tuberculosis in adults living with HIV/AIDS in Malawi

  2021cites this paper
• Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis

  2021cites this paper
• The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis

  2021cites this paper
• Annual Tuberculosis Preventive Therapy for Persons With HIV Infection

  2021cites this paper
• “If I’ve got latent TB, I would like to get rid of it”: Derivation of the CARD (Constraints, Actions, Risks, and Desires) Framework informed by South African healthcare worker perspectives on latent tuberculosis treatment

  2021cites this paper
• Yield of repeat tuberculin skin testing for people living with HIV in Brazil.

  2021cites this paper
• The role and challenges of cluster randomised trials for global health.

  2021cites this paper
• HIV in the Kingdom of Saudi Arabia: Can We Change the Way We Deal with Co-Infections

  2021cites this paper
• Risk of developing active tuberculosis following tuberculosis screening and preventive therapy for Tibetan refugee children and adolescents in India: An impact assessment

  2021cites this paper
• Cost‐effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda

  2020cites this paper
• Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

  2020cites this paper
• An evaluation of 6-month versus continuous isoniazid preventive therapy for M. tuberculosis in adults living with HIV/AIDS in Malawi.

  2020cites this paper
• Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV.

  2020cites this paper
• Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data

  2020cites this paper
• Cost-effectiveness of newer technologies for the diagnosis of Mycobacterium tuberculosis infection in Brazilian people living with HIV

  2020cites this paper
• The Role of Metallic Nanoparticles in Inhibition of Mycobacterium Tuberculosis and Enhances Phagosome Maturation into the Infected Macrophage

  2020cites this paper
• Access and adherence to isoniazid preventive therapy and occurrence of active TB in a cohort of people living with HIV: a retrospective cohort study in Sao Paulo, Brazil

  2020cites this paper
• Antiretroviral treatment for HIV infection: Swedish recommendations 2019

  2020cites this paper
• TB-HIV co-infection: spatial and temporal distribution in the largest Brazilian metropolis

  2020cites this paper
• New opportunities in tuberculosis prevention: implications for people living with HIV

  2020cites this paper
• Conference proceedings from the 22nd Bangkok International Symposium on HIV Medicine

  2020cites this paper
• Korelasi Jumlah CD4 Pasien Yang Diberi Isoniazid Dengan Ko-infeksi TB Pada Pasien HIV/AIDS

  2020cites this paper
• Treatment for latent tuberculosis infection in low- and middle-income countries: progress and challenges with implementation and scale-up

  2019cites this paper
• Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection

  2019cites this paper
• The Global Landscape of Tuberculosis Therapeutics.

  2019cites this paper
• Systematic review showed that stepped-wedge cluster randomized trials often did not reach their planned sample size.

  2019cites this paper
• One Month of Rifapentine plus Isoniazid to Prevent HIV‐Related Tuberculosis

  2019cites this paper
• Tuberculosis risk factors and Mycobacterium tuberculosis transmission among HIV-infected patients in Vietnam.

  2019cites this paper
• Comparative analysis of the effectiveness of tuberculosis prophylaxis in patients with HIV/AIDS treated with isoniazid.

  2019cites this paper
• Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral Therapy

  2019cites this paper
• 70 years of TB Prevention: Efficacy, Effectiveness, Toxicity, Durability and Duration.

  2019cites this paper
• CD4 count stratification to guide tuberculosis preventive therapy for people living with HIV.

  2019cites this paper
• THE VALUE OF DIFFERENT TUBERCULOSIS (TB) CASE DETECTION STRATEGIES IN CHILDHOOD TB CONTROL IN A HIGH-TB BURDEN POPULATION DENSE AREA, WESTERN KENYA, 2012-2015: A CLUSTER RANDOMIZED TRIAL

  2019cites this paper
• Primary Prophylaxis to Prevent Tuberculosis Infection in Prison Inmates: A Randomized, Double-Blind, Placebo-Controlled Trial.

  2019cites this paper
• Epidemiology in History Seventy Years of Tuberculosis Prevention: Ef fi cacy, Effectiveness, Toxicity, Durability, and Duration

  2019cites this paper
• LATENT TUBERCULOSIS AMONG PEOPLE WITH HIV/AIDS TUBERCULOSE LATENTE ENTRE PESSOAS COM HIV/AIDS TUBERCULOSIS LATENTE ENTRE PERSONAS CON VIH / SIDA

  2018cites this paper
• TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings.

  2018cites this paper
• Tuberculosis: renewed challenge in Brazil.

  2018cites this paper
• Transcriptomic signatures of recurrent tuberculosis disease and treatment response in HIV-infected individuals

  2018cites this paper
• Diagnosis and therapeutic approach of latent tuberculosis infection.

  2018cites this paper
• Cost-effectiveness of Preventive Therapy for Tuberculosis With Isoniazid and Rifapentine Versus Isoniazid Alone in High-Burden Settings

  2018cites this paper
• THE EFFECT OF ISONIAZID PREVENTIVE THERAPY ON THE OCCURRENCE OF TUBERCULOSIS IN LESOTHO, SOUTHERN AFRICA

  2018cites this paper
• The Value of Household Contact Investigation in Control Of Drug-Susceptible Tuberculosis Among Children Aged 0-5 Years in Kisumu County Kenya.

  2018cites this paper
• Tuberculosis burden on AIDS in Brazil: A study using linked databases

  2018cites this paper
• Preventive therapy for HIV-associated tuberculosis

  2018cites this paper
• Experiences of people living with HIV with respect to Isoniazid Preventive Therapy provision in Mafikeng PHC facilities

  2018cites this paper
• A score to predict and stratify risk of tuberculosis in adult contacts of tuberculosis index cases: a prospective derivation and external validation cohort study

  2017cites this paper
• Is it time for Brazil to prioritize TB preventive therapy for all people living with HIV?

  2017cites this paper
• Perceptions of professional nurses about the barriers and enhancers to the implementation of isoniazid preventative therapy amongst HIV positive adults

  2017cites this paper
• Public Health Issues

  2017cites this paper
• Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.

  2017cites this paper
• Diagnosis and therapeutic approach of latent tuberculosis infection.

  2017cites this paper
• Ga(III) Nanoparticles Inhibit Growth of both Mycobacterium tuberculosis and HIV and Release of Interleukin-6 (IL-6) and IL-8 in Coinfected Macrophages

  2017cites this paper
• Is systematic screening and treatment for latent tuberculosis infection in HIV patients useful in a low endemic setting?

  2017cites this paper
• Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV

  2016cites this paper
• Status and Clinical Application of AIDS Complications Imaging

  2016cites this paper
• O tratamento da coinfecção HIV-TB

  2016influential citation
• Characterization of resistance profile of Mycobacterium tuberculosis isolates from patients with tuberculosis in Beira, Sofala - Mozambique

  2016cites this paper
• 艾滋病并发症的影像学研究现状与临床应用 Research Status and Clinical Application of AIDS Complications Imaging

  2016cites this paper
• Optimal Use of New and Existing Drugs for Tuberculosis Control

  2016cites this paper
• Year in review 2015: Lung cancer, pleural diseases, respiratory infections, bronchiectasis and tuberculosis, bronchoscopic intervention and imaging

  2016cites this paper
• Diagnosis and management of latent tuberculosis

  2016cites this paper
• Screening and treatment of latent tuberculosis infection among HIV-infected patients in resource-rich settings

  2016cites this paper
• Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic

  2016cites this paper
• Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil

  2016cites this paper
• Post-treatment effect of isoniazid preventive therapy on tuberculosis incidence in HIV-infected individuals on antiretroviral therapy

  2016influential citation
• What factors may influence epidemiological situation of tuberculosis in Poland and in the world?

  2016cites this paper
• Stepped wedge cluster randomised trials: a review of the statistical methodology used and available

  2016cites this paper
• The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study

  2016cites this paper
• Mycobacterial Lung Disease Complicating HIV Infection

  2016cites this paper
• Poor agreement between diagnostic tests for latent tuberculosis infection among HIV‐infected persons in Hong Kong

  2016cites this paper
• Risk of Active Tuberculosis in HIV-Infected Patients in Taiwan with Free Access to HIV Care and a Positive T-Spot.TB Test

  2015cites this paper
• Latent Mycobacterium tuberculosis infection.

  2015cites this paper
• A review of rifapentine for treating active and latent tuberculosis

  2015cites this paper
• Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection.

  2015cites this paper
• Key challenges in the current TB & HIV information system in South Africa: a case study in Khayelitsha, Western Cape

  2015cites this paper
• Clinical and laboratory features of HIV/AIDS in the Kingdom of Saudi Arabia

  2015cites this paper